Exon recognition during constitutive pre-mRNA splicing
Exon recognition during constitutive pre-mRNA splicing
批准号:
8323463
负责人:
Lawrence Allen Chasin
金额:
$45.37万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-08-01 至 2014-08-31
关键词:
AffectCellsChemistryChromatin StructureCodeCollectionCommunicationComputational BiologyDNADependenceElementsEnhancersEventExhibitsExonsGenesGeneticGenetic TranscriptionGenetic TranslationHereditary DiseaseHumanHuman GeneticsHuman GenomeIntronsKnowledgeLearningMalignant NeoplasmsMeasuresMessenger RNAMethodsMolecularMolecular GeneticsMutagenesisNatureNucleotidesPatternPlayPositioning AttributePostdoctoral FellowProcessPromoter RegionsPropertyProtein BindingProteinsRNARNA Polymerase IIRNA SplicingReactionRegulator GenesRegulatory ElementRelative (related person)RoleSignal TransductionSiteSurveysSystemTestingTherapeutic UsesTranscriptTranscriptional Silencer ElementsTranslatingWorkcancer cellcell typedensitydesigngenome sequencinggraduate studentmRNA Precursorpreventpublic health relevanceresearch studyresponsetumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The expression of the genetic information inherent in our DNA includes 4 basic processes: 1) transcription into RNA, 2) splicing together the fragments of information in this RNA into messenger RNA, or mRNA ; 3) translation of the mRNA into proteins; 4) modifying the proteins to make them effective. This proposal focuses on the second process, pre-mRNA splicing. Although the chemistry of the splicing reaction is fairly well understood, it is not yet clear as how the cell recognizes the demarcation of the few relatively short regions of the pre-mRNA that code for protein (the exons, ~100 nucleotides (nt) long, ~10 per transcript) within a long (~20,000 nt) pre-mRNA molecule. The splice sites themselves are comprised of sequences with specific features. For example, each spliced out region (the intron) almost always starts with a GT and ends with an AG sequence. However, the splice site sequences are not distinctive enough to provide an unambiguous mark. We will pursue 4 approaches with the aim of deciphering the "splicing code," i.e., the sequence elements and rules that allow recognition of splice sites lying within the sequence of the pre-mRNA or DNA: 1) We will add all possible sequences of 6 nt (4096) into a weakened exon to define the complete list of those that can enhance splicing. By repeating this experiments and comparing the sequences found after altering the exon in various ways, we will learn how different parts of the overall sequence interact to create a signal. These experiments exploit recently developed methods for massive sequencing of short regions of DNA. 2) We have found that limited intronic regions just outside the exon can play powerful roles in splice site recognition but little is known about the general nature or action of these sequences. We will investigate the effect of the position and protein-binding properties of these intronic enhancers on splicing and on chromatin structure. Our use of a cellular gene for this purpose is an improvement over less natural test systems currently in use. 3) It now appears that the density of signals influencing splicing is very high, so that any manipulation of a natural sequence is likely to change more than one signal at once. To minimize this effect we will build synthetic exons designed using insulated modules of known effect (enhancers and silencers of splicing). By placing these modules in various permutations, we will learn the rules governing their interactions. 4) Statistical analysis of the human genome sequence has allowed the successful prediction of exonic enhancers and silencers. We will extend such computational approaches to search for intronic and exonic signals that cooperate to enhance splicing and that may act to silence false splice sites. Many human genetic diseases are caused by splicing deficiencies and cancer cells often exhibit abnormal splicing patterns. A knowledge of the splicing code will enable this process to be targeted for therapeutic use, such as correcting a deficiency in a genetic disease, or disrupting a harmful splicing event in a tumor.
PUBLIC HEALTH RELEVANCE:
Human genes control our lives by having their information translated into the proteins that operate our cells. That genetic information is present as fragments that must be spliced together to make any sense, and disruption of the splicing process causes many genetic diseases and can contribute to cancer. Our proposal is aimed at understanding how this splicing takes place.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exon recognition during constitutive pre-mRNA splicing
-
批准号:8145635
-
项目类别:
-
资助金额:$45.37万
-
财政年份:2005
-
负责人:Lawrence Allen Chasin
-
依托单位:
Exon recognition during constitutive pre-mRNA splicing
-
批准号:6966860
-
项目类别:
-
资助金额:$30.48万
-
财政年份:2005
-
负责人:Lawrence Allen Chasin
-
依托单位:
Exon recognition during constitutive pre-mRNA splicing
-
批准号:7987291
-
项目类别:
-
资助金额:$31.83万
-
财政年份:2005
-
负责人:Lawrence Allen Chasin
-
依托单位:
Exon recognition during constitutive pre-mRNA splicing
-
批准号:7105514
-
项目类别:
-
资助金额:$29.86万
-
财政年份:2005
-
负责人:Lawrence Allen Chasin
-
依托单位:
Exon recognition during constitutive pre-mRNA splicing
-
批准号:8141913
-
项目类别:
-
资助金额:$14.23万
-
财政年份:2005
-
负责人:Lawrence Allen Chasin
-
依托单位:
Exon recognition during constitutive pre-mRNA splicing
-
批准号:7469442
-
项目类别:
-
资助金额:$29.18万
-
财政年份:2005
-
负责人:Lawrence Allen Chasin
-
依托单位:
Exon recognition during constitutive pre-mRNA splicing
-
批准号:8573046
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2005
-
负责人:Lawrence Allen Chasin
-
依托单位:
Exon recognition during constitutive pre-mRNA splicing
-
批准号:8535161
-
项目类别:
-
资助金额:$55.36万
-
财政年份:2005
-
负责人:Lawrence Allen Chasin
-
依托单位:
Exon recognition during constitutive pre-mRNA splicing
-
批准号:7261326
-
项目类别:
-
资助金额:$29.09万
-
财政年份:2005
-
负责人:Lawrence Allen Chasin
-
依托单位:
MOLECULAR BIOLOGY CORE INSTRUMENTATION FACILITY
-
批准号:3521128
-
项目类别:
-
资助金额:$10.4万
-
财政年份:1991
-
负责人:Lawrence Allen Chasin
-
依托单位:
THE CHEMICAL AND MOLECULAR BASIS OF BIOLOGICAL PROCESSES
-
批准号:3537019
-
项目类别:
-
资助金额:$25.43万
-
财政年份:1987
-
负责人:Lawrence Allen Chasin
-
依托单位:
THE CHEMICAL AND MOLECULAR BASIS OF BIOLOGICAL PROCESSES
-
批准号:3537020
-
项目类别:
-
资助金额:$30.91万
-
财政年份:1987
-
负责人:Lawrence Allen Chasin
-
依托单位:
THE CHEMICAL AND MOLECULAR BASIS OF BIOLOGICAL PROCESSES
-
批准号:3537018
-
项目类别:
-
资助金额:$22.33万
-
财政年份:1987
-
负责人:Lawrence Allen Chasin
-
依托单位:
THE CHEMICAL AND MOLECULAR BASIS OF BIOLOGICAL PROCESSES
-
批准号:3537021
-
项目类别:
-
资助金额:$31.33万
-
财政年份:1987
-
负责人:Lawrence Allen Chasin
-
依托单位:
THE CHEMICAL AND MOLECULAR BASIS OF BIOLOGICAL PROCESSES
-
批准号:3537014
-
项目类别:
-
资助金额:$17.7万
-
财政年份:1987
-
负责人:Lawrence Allen Chasin
-
依托单位:
THE CHEMICAL AND MOLECULAR BASIS OF BIOLOGICAL PROCESSES
-
批准号:3537016
-
项目类别:
-
资助金额:$4.06万
-
财政年份:1987
-
负责人:Lawrence Allen Chasin
-
依托单位:
MAMMALIAN CELL GENETIC STUDIES OF PREMRNA SPLICING
-
批准号:2518888
-
项目类别:
-
资助金额:$41.44万
-
财政年份:1978
-
负责人:Lawrence Allen Chasin
-
依托单位:
ANALYSIS OF DIHYDROFOLATE REDUCTASE GENE EXPRESSION
-
批准号:3271245
-
项目类别:
-
资助金额:$30.99万
-
财政年份:1978
-
负责人:Lawrence Allen Chasin
-
依托单位:
ANALYSIS OF DIHYDROFOLATE REDUCTASE GENE EXPRESSION
-
批准号:3271239
-
项目类别:
-
资助金额:$28.43万
-
财政年份:1978
-
负责人:Lawrence Allen Chasin
-
依托单位:
MAMMALIAN CELL GENETIC STUDIES OF PREMRNA SPLICING
-
批准号:2173958
-
项目类别:
-
资助金额:$39.85万
-
财政年份:1978
-
负责人:Lawrence Allen Chasin
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: